BTS
RDY icon

BB&T Securities’s Dr. Reddy's Laboratories RDY Stock Holding History

BB&T Securities’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,000
Closed -$205K – 1270
2016
Q2 		$205K Buy
+20,000
New +$183K ﹤0.01% 1128

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB&T Securities's RDY Position: Q3 2016 in Review

BB&T Securities sold out of Dr. Reddy's Laboratories (RDY) in Q3 2016, closing a stake of 20,000 shares — an estimated $205K sold.

BB&T Securities first reported a position in RDY in Q2 2016 and held it in 1 quarter. The position peaked at $205K in Q2 2016. 157 funds tracked by Wall St. Rank hold RDY as of Q3 2016.

  • BB&T Securities reported no remaining Dr. Reddy's Laboratories position as of Q3 2016 after selling out during the quarter.
  • BB&T Securities sold 20,000 Dr. Reddy's Laboratories shares in Q3 2016, an estimated $205K.
  • BB&T Securities first reported a position in Dr. Reddy's Laboratories in Q2 2016 and held it in 1 quarter.
  • BB&T Securities's Dr. Reddy's Laboratories position peaked at $205K in Q2 2016.
  • 157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2016.

Based on BB&T Securities's 13F filing for Q3 2016, filed 9 Nov 2016.